gastrointestinal cancer
Conditions
Interventions
None listed
Sponsors
Nishimura Takahiro
Eligibility
Inclusion criteria
Inclusion criteria: Patients who received oxaliplatin as treatment for gastrointestinal cancer at our hospital between January 2017 and December 2023.
Exclusion criteria
Exclusion criteria: Patients who have expressed their refusal to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Allergy incidence | — |
Contacts
Public ContactMaho Tanaka
Japan Institute for Health Security
Outcome results
None listed